Chargement en cours...
Intravitreal bevacizumab improves the clearance of vitreous haemorrhage and visual outcomes in patients with proliferative diabetic retinopathy
OBJECTIVE: To evaluate the occurrence of vitreous haemorrhage (VH) secondary to proliferative diabetic retinopathy (PDR) and the efficacy of intravitreal bevacizumab (IVB) for VH in 5-year real-life data. METHODS AND ANALYSIS: 850 adult patients with type 1 (T1D) or type 2 diabetes (T2D) with PDR we...
Enregistré dans:
| Publié dans: | BMJ Open Ophthalmol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMJ Publishing Group
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6936487/ https://ncbi.nlm.nih.gov/pubmed/31909195 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjophth-2019-000390 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|